Improved diagnosis and management of one of the most common cancers in men – prostate cancer – could result from research at the University of Adelaide, which has discovered that seminal fluid (semen) contains biomarkers for the disease.
Results of a study now published in the journal Endocrine-Related Cancer have shown that the presence of certain molecules in seminal fluid indicates not only whether a man has prostate cancer, but also the severity of the cancer.
Read more . . .
The Latest on: Prostate cancer biomarkers
[google_news title=”” keyword=”Prostate cancer biomarkers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Prostate cancer biomarkers
- Immunotherapy: A Beacon of Hope in Cancer Treatmenton May 3, 2024 at 9:48 pm
Cancer, a disease that has plagued humanity for centuries, has finally met its match in immunotherapy, a revolutionary treatment that harnesses the power of the immune system to combat this deadly ...
- Prostate Cancer Newson May 2, 2024 at 5:00 pm
Until now, the precise mechanism ... New Prostate Cancer Biomarkers Provide Hope to Millions of Men July 19, 2023 — Three new biomarkers for prostate cancer have been identified to help pinpoint ...
- Prostate cancer screening trial ‘pivotal moment in history’: Tech & Science Daily podcaston May 1, 2024 at 5:04 am
The trial, commissioned by Prostate Cancer UK and led by London universities ... toxic metals - including uranium - that could harm the brain and other vital organs. Biomarkers in participants’ urine ...
- Adelaide research breakthrough hopes to provide more accurate prostate cancer diagnosis and treatmenton April 30, 2024 at 2:08 pm
An Adelaide research team has identified precise biomarkers for prostate cancer, making it easier to predict how the disease could progress with the hope it will lead to more accurate treatment.
- Cancer Biomarkers Market Worth $42.0 billion | MarketsandMarketson April 29, 2024 at 7:41 am
Cancer Biomarkers Market in terms of revenue was estimated to be worth $24.5 billion in 2024 and is poised to reach $42.0 billion by 2029, growing at ...
- Prostate Cancer Breakthrough: Urine Test Avoids Unnecessary Biopsieson April 28, 2024 at 9:57 pm
A study in JAMA Oncology reveals that MyProstateScore 2.0, a new urine test analyzing 18 genes, surpasses PSA in detecting significant prostate cancers and could reduce unnecessary biopsies by up to ...
- Vietnam Prostate Cancer Biomarker Market Future Heights Unveiled Exploring Market Size’s Ascending Pathon April 24, 2024 at 2:00 pm
Report Ocean’s latest analysis delves into the “Vietnam Prostate Cancer Biomarker Market” Report from 2024 to 2032, covering an array of market facets such as characteristics, size, growth, ...
- New Prostate Cancer Urine Test Has High Diagnostic Accuracyon April 22, 2024 at 11:30 pm
A new prostate cancer test has higher diagnostic accuracy for high-grade disease than current guideline-endorsed biomarkers, according to a study published online April 18 in JAMA Oncology. Jeffrey J.
- New Urine Test for Prostate Cancer May Help Reduce Unnecessary Biopsieson April 22, 2024 at 4:19 am
A prostate cancer biomarker test that utilizes genes indicating high-grade prostate cancer appears highly accurate.
- Novel 18-Gene Urine Test Better Detects Clinically Significant Prostate Canceron April 21, 2024 at 5:00 pm
The MyProstateScore 2.0 urine test captures 17 biomarkers of clinically significant prostate cancer, independent of PSA. A positive result can rule in and a negative result can rule out the need for ...
via Bing News